Jan 24, 2019 12:15:00 AM PromarkerD US market update Proteomics Share: facebook-f icon linkedin-in icon Twitter icon pinterest-p icon envelope icon Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners. Media release 2019
